![structure glp 1 of [ 3 H]liraglutide (top) and the GLP-1 receptor agonists GLP-1R Agonist DMB | Glucagon](https://www.researchgate.net/profile/Inga-Bjornsdottir-2/publication/45650716/figure/fig2/AS:667822585806848@1536232720030/Structure-of-3-Hliraglutide-top-and-the-GLP-1-receptor-agonists-liraglutide-and.png)
structure glp 1 of [ 3 H]liraglutide (top) and the GLP-1 receptor agonists GLP-1R Agonist DMB | Glucagon
Description
No standardized dosing guideline has been published
![structure glp 1 of [ 3 H]liraglutide (top) and the GLP-1 receptor agonists GLP-1R Agonist DMB | Glucagon](https://cdn.targetmol.com/group3/M00/35/BC/CgoaEGayKi-EdXJHAAAAACVl4Hs557.png)
Additionally, GLP-1 agonists may cause side effects, such as nausea, vomiting, and diarrhea
![structure glp 1 of [ 3 H]liraglutide (top) and the GLP-1 receptor agonists GLP-1R Agonist DMB | Glucagon](https://www.diamond.ac.uk/dam/jcr:38366c36-f774-40eb-acca-e0938ae00220/p20fig1.jpg)
By combining computational tools with biological and chemical data, bioinformatics has significantly accelerated drug development, enhanced success rates, and reduced associated costs, making it an essential resource for creating innovative therapeutics and optimizing drug performance [26]
![structure glp 1 of [ 3 H]liraglutide (top) and the GLP-1 receptor agonists GLP-1R Agonist DMB | Glucagon](https://www.mdpi.com/molecules/molecules-30-00012/article_deploy/html/images/molecules-30-00012-g001-550.jpg)
W., Lingvay, I., Reed, J., De La Rosa, R., Rose, L., Sugimoto, D., Araki, E., Chu, P
![structure glp 1 of [ 3 H]liraglutide (top) and the GLP-1 receptor agonists GLP-1R Agonist DMB | Glucagon](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnature22800/MediaObjects/41586_2017_Article_BFnature22800_Fig1_HTML.jpg)
Another limitation is the need for consistency
![structure glp 1 of [ 3 H]liraglutide (top) and the GLP-1 receptor agonists GLP-1R Agonist DMB | Glucagon](https://cdn.rcsb.org/images/structures/3iol_model-1.jpeg)
